Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial.
Christensen B, Nellemann B, Larsen MS, Thams L, Sieljacks P, Vestergaard PF, Bibby BM, Vissing K, Stødkilde-Jørgensen H, Pedersen SB, Møller N, Nielsen S, Jessen N, Jørgensen JO. Christensen B, et al. Among authors: bibby bm. Am J Physiol Endocrinol Metab. 2013 Oct 1;305(7):E879-89. doi: 10.1152/ajpendo.00269.2013. Epub 2013 Aug 6. Am J Physiol Endocrinol Metab. 2013. PMID: 23921143 Free article. Clinical Trial.
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
Gejl M, Søndergaard HM, Stecher C, Bibby BM, Møller N, Bøtker HE, Hansen SB, Gjedde A, Rungby J, Brock B. Gejl M, et al. Among authors: bibby bm. J Clin Endocrinol Metab. 2012 Jul;97(7):E1165-9. doi: 10.1210/jc.2011-3456. Epub 2012 Apr 27. J Clin Endocrinol Metab. 2012. PMID: 22544917 Clinical Trial.
Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans.
Lerche S, Brock B, Rungby J, Bøtker HE, Møller N, Rodell A, Bibby BM, Holst JJ, Schmitz O, Gjedde A. Lerche S, et al. Among authors: bibby bm. Diabetes. 2008 Feb;57(2):325-31. doi: 10.2337/db07-1162. Epub 2007 Nov 8. Diabetes. 2008. PMID: 17991759 Clinical Trial.
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.
Gejl M, Egefjord L, Lerche S, Vang K, Bibby BM, Holst JJ, Mengel A, Møller N, Rungby J, Brock B, Gjedde A. Gejl M, et al. Among authors: bibby bm. J Cereb Blood Flow Metab. 2012 Dec;32(12):2146-52. doi: 10.1038/jcbfm.2012.118. Epub 2012 Aug 29. J Cereb Blood Flow Metab. 2012. PMID: 22929437 Free PMC article. Clinical Trial.
118 results